Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 27, 2008

View Archived Issues

FTY-720 associated with viral clearance in models of infection

TRPM8 antagonism may attenuate hypersensitivity to cold

NP-12 reduces tau and beta-amyloid pathology in mice

Recent patents report novel treatment options for endocrine disorders

Novel Rac1/Rac1b inhibitors prevent Abeta production, display improved metabolic stability

Animal model of siRNA therapy for HIV infection created

FG-4497 shows promise in rat kidney transplant model

EP-1013 enhances effects of costimulation blockade for islet transplantation

Pfizer unveils potent and selective c-Met inhibitor PF-4254644

New analgesic agents disclosed in recent patent literature

Recent Roche patent describes new treatments for depression, anxiety

Otsuka acquires Interpharma Praha from Interpharma West

AVEO initiates phase Ib combination trial of AV-951 and FOLFOX-6

Avexa and Shire renegotiate apricitabine license agreement

Biofrontera and DSE form license agreement for U.S. Relieva distribution

Galapagos acquires Sareum Holdings' structure-based drug discovery services

Genzyme and Medicines for Malaria Venture collaborate with Advinus

Novosom acquires exclusive license for Isis' CD40-targeted antisense inhibitors

Phase II IMC-A12 and IMC-1121B trial enrolls advanced prostate cancer patients

Zostavax approved in Canada for the prevention of shingles

Ark commences patient enrollment in phase III Vitor pilot study in cachexia

Curis doses first patient in phase I CUDC-101 trial

FDA fast tracks droxidopa for symptomatic neurogenic orthostatic hypotension

FDA grants Glivec priority review for gastrointestinal stromal tumors

FDA issues complete response letter for paliperidone palmitate for schizophrenia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...